Gut Microbiome and Longevity : What Centenarians Have in Common

In the early 1900s, Élie Metchnikoff — Russian biologist and 1908 Nobel laureate in Physiology or Medicine — advanced a hypothesis that his contemporaries found eccentric: the exceptional longevity of Bulgarian peasants was connected to their daily consumption of fermented yogurt. That intuition anticipated by a century the scientific revolution now unfolding in microbiome research.

The gut microbiome is currently one of the most actively studied fields in human biology — and one of the most generously funded. Among its most productive lines of investigation: the relationship between microbiota composition and biological longevity. What began as an observation about yogurt has become, through genome sequencing, cohort studies, and mechanistic research, one of the more consequential scientific stories of the decade.

An invisible organ with measurable functions

The gut microbiome comprises the full community of microorganisms — bacteria, archaea, fungi, viruses, and protists — colonising the human digestive tract. Estimates put their number at somewhere between 38 and 100 trillion, with a combined mass of roughly one to two kilograms. Their collective genome — the metagenome — contains approximately 150 times more genes than the human genome itself.

That genomic depth equips the microbiome with metabolic capabilities the host organism cannot achieve alone: fermentation of dietary fibre into short-chain fatty acids, synthesis of vitamins including K2, B12, and folates, regulation of the intestinal immune system, and maintenance of the epithelial barrier that separates the gut lumen from systemic circulation.

The microbiome is not a passive inhabitant. It is a co-evolutionary partner whose functions have been woven into human physiology over millions of years — a point that the 2023 revision of the Hallmarks of Aging framework formalised by listing dysbiosis as a hallmark in its own right for the first time [López-Otín et al., Cell, 2023].

How the microbiome changes with age

In young, healthy adults, the gut microbiome is dominated by two major bacterial phyla: Firmicutes and Bacteroidetes. Diversity is high, and composition is relatively stable across years.

With age, a characteristic set of changes has been documented across multiple independent cohorts.

Bacterial diversity declines. This is the most consistent and most studied marker of microbiome aging. A landmark study by Claesson and colleagues, published in Nature in 2012, examined 178 elderly Irish individuals and found that microbiome composition was tightly correlated with overall health status — more strongly than with age alone. The least diverse microbiomes belonged to the most institutionalised, least mobile, and least healthy individuals.

Pro-inflammatory species expand. The proportion of bacteria that produce short-chain fatty acids — including Faecalibacterium prausnitzii and Roseburia intestinalis, both with well-characterised anti-inflammatory properties — declines with age. Opportunistic pro-inflammatory species move in to fill the gap.

Intestinal permeability increases. As the microbial community that maintains the gut epithelial barrier deteriorates, bacterial fragments — principally lipopolysaccharide (LPS) — leak into systemic circulation, where they activate TLR4 receptors on innate immune cells. The result is a chronic low-grade endotoxaemia that directly fuels inflammaging: the persistent, sterile systemic inflammation that is one of the central hallmarks of biological aging.

This sequence — dysbiosis → barrier breakdown → systemic LPS → innate immune activation → inflammaging — places the microbiome at the intersection of multiple aging hallmarks simultaneously: Hallmark 12 (dysbiosis), Hallmark 11 (chronic inflammation), and Hallmark 10 (altered intercellular communication).

What centenarian microbiomes reveal

If microbiome composition merely reflected health status, centenarians would be expected to show heavily degraded microbial communities. The research suggests the opposite.

Biagi and colleagues (Current Biology, 2016) compared the microbiomes of Italian centenarians, supercentenarians (aged 105 and older), elderly controls, and young adults. Centenarians showed a distinct microbial profile — characterised by preserved diversity, greater abundance of certain beneficial species, and a composition that in several respects resembled that of younger adults more than that of their age peers.

Studies in Sardinian, Chinese, and Japanese centenarian populations have found convergent signatures — suggesting that certain features of the longevity-associated microbiome are not population-specific. The finding that recurs most consistently is this: people who live to 100 in good functional health tend to have a gut microbiome that looks, microbiologically, younger than their chronological age would predict.

Wilmanski and colleagues (Nature Metabolism, 2021), studying a cohort of more than 9,000 individuals, found that healthy adults over 80 showed a statistically distinct microbiome composition — with preserved diversity and specific metabolic signatures associated with lower all-cause mortality. The metabolite profiles of these individuals also suggested active microbial production of beneficial compounds, not merely the absence of dysbiosis.

Akkermansia muciniphila: the bacterium that earns its prominence

Among the bacterial species whose relationship with healthy aging is best documented, Akkermansia muciniphila occupies a prominent position — and for specific reasons.

Akkermansia colonises the mucosal layer of the intestinal epithelium, where it feeds on mucus and, in doing so, continuously stimulates its renewal. This activity directly supports the integrity of the gut barrier. Multiple studies have shown an inverse correlation between Akkermansia abundance and metabolic syndrome, obesity, type 2 diabetes, and chronic systemic inflammation.

The mechanism involves more than barrier maintenance. Akkermansia produces specific proteins — including the outer membrane protein Amuc_1100 — that interact directly with TLR2 receptors on intestinal epithelial cells, modulating immune tone and reducing inflammatory signalling. It also promotes the production of glucagon-like peptide 1 (GLP-1), improving glucose homeostasis through a pathway independent of direct glucose sensing.

In centenarian cohorts, Akkermansia abundance is consistently elevated relative to age-matched healthy elderly controls — a finding now reproduced across multiple countries and study designs.

Fecal transplantation: the direct experimental test

One of the most striking pieces of evidence for a causal role of the microbiome in aging comes from fecal microbiota transplantation (FMT) experiments in animal models.

Transferring the gut microbiome of aged mice into young germ-free mice accelerates several markers of brain aging in the recipients — including neuroinflammation, reduced hippocampal neurogenesis, and impaired cognitive performance. Conversely, transferring a young microbiome into aged mice improves cognitive function and reduces inflammatory markers in the brain [Boehme et al., Nature Aging, 2021].

These results cannot prove direct causality in humans. But they establish something important: the microbiome is not simply a downstream reflection of health status. It actively shapes the biological environment of the host — including the brain — through metabolic and immune signalling that reaches far beyond the gut.

Butyrate: the microbial metabolite with epigenetic reach

Short-chain fatty acids — butyrate, propionate, and acetate, produced by bacterial fermentation of dietary fibre — are among the best-studied outputs of a healthy microbiome. Their systemic effects go well beyond gut health.

Butyrate is the primary energy source for colonocytes, the cells lining the large intestine. It also crosses the blood-brain barrier, where it exerts documented neuroprotective and anti-inflammatory effects. In the brain, it reduces microglial activation — the chronic neuroinflammation that drives age-related cognitive decline [Cryan et al., Nature Reviews Neuroscience, 2019].

At the epigenetic level, butyrate is a histone deacetylase (HDAC) inhibitor — meaning it directly modulates the chromatin modifications that regulate gene expression. This places microbially produced butyrate in direct contact with one of the twelve Hallmarks of Aging: epigenetic alteration. The gut microbiome, through its metabolic outputs, reaches into the cell's epigenetic control machinery.

The dietary implication is direct. Fibre deprivation — characteristic of ultra-processed diets — does not simply reduce substrate for bacterial fermentation. It starves the organisms that produce butyrate, depresses their populations, and progressively erodes the epithelial and systemic benefits their metabolic activity generates. A 2022 study by Wastyk and colleagues in Cell found that high-fibre diets increase microbiome diversity, while high-fermented-food diets reduce inflammatory protein markers — two complementary levers operating through distinct mechanisms.

Urolithin A: when the microbiome determines whether nutrition works

Urolithin A is a metabolite produced by the intestinal biotransformation of ellagitannins — polyphenols found in pomegranates, walnuts, and certain berries. The transformation is performed by specific gut bacteria, primarily in the Gordonibacter and Ellagibacter genera.

Clinical studies published in Nature Metabolism and Cell Reports Medicine have shown that urolithin A activates mitophagy — the selective clearance of damaged mitochondria — and measurably improves muscle function and endurance in older adults.

The broader point this raises is significant: the capacity to produce certain bioactive longevity-relevant metabolites is not universal. It is contingent on the presence of specific bacteria in sufficient abundance. Approximately 30 to 40% of the population may not produce meaningful amounts of urolithin A regardless of dietary ellagitannin intake — because the necessary bacterial machinery is absent or inadequate.

This is one of the clearest demonstrations that the microbiome is not background noise in longevity biology. It is, for a meaningful fraction of the population, the limiting factor determining whether nutritional inputs are converted into biological benefit.

What geroscience has established

The gut microbiome is a functional organ. Its composition directly conditions several mechanisms central to longevity: intestinal barrier integrity, production of bioactive metabolites, regulation of systemic immunity, protection against inflammaging, and bidirectional communication with the central nervous system.

The decision by López-Otín and colleagues to include dysbiosis as a formal Hallmark of Aging in the 2023 revision of their framework reflects a decade of accumulating evidence that the microbiome is not peripheral to aging biology. It is embedded in it.

What the centenarian data consistently shows — across Italy, Japan, Sardinia, and China — is that the microbiomes of the longest-lived individuals look younger than their age. Diversity is preserved. Beneficial species persist. The metabolic outputs that support barrier integrity, reduce inflammation, and reach the brain remain active.

Metchnikoff had an intuition. Contemporary geroscience has made it a science.

References: Claesson et al., Nature (2012) · Biagi et al., Current Biology (2016) · Wilmanski et al., Nature Metabolism (2021) · Boehme et al., Nature Aging (2021) · Cryan et al., Nature Reviews Neuroscience (2019) · Wastyk et al., Cell (2022) · López-Otín et al., Cell (2023)

This article is published for informational and educational purposes only. It does not constitute medical advice and is not a substitute for professional healthcare consultation.